Frequency of Circulating CD8+CD73+T Cells Is Associated With Survival in Nivolumab-Treated Melanoma Patients
Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-020-02285-0
Full Text
Open PDFAbstract
Available in full text
Date
March 11, 2020
Authors
Publisher
Springer Science and Business Media LLC